Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism TXNIP modulators(thioredoxin interacting protein modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H15N5O2 |
InChIKeyONZGILNKQYWMNI-UHFFFAOYSA-N |
CAS Registry432016-77-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Preclinical | CN | 15 May 2017 |